Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Civitas Solutions, Inc. (CIVI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/20/2019 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Civitas, Entegra, and Immune Design on Behalf of Stockholders and Encourages Investors to Contact the Firm |
03/18/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
03/11/2019 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in Civitas Solutions, Inc. |
03/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
03/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
03/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
03/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
03/08/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
03/08/2019 |
8-K
| Quarterly results |
03/08/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
03/06/2019 |
GN
| Analysis: Positioning to Benefit within Bristol-Myers Squibb, AAR, Central Garden & Pet, Alexion Pharmaceuticals, Tribune Media, and Civitas Solutions — Research Highlights Growth, Revenue, and Consolidated Results |
02/28/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
02/28/2019 |
8-K
| Quarterly results |
02/22/2019 |
GN
| CIVITAS SOLUTIONS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout |
02/14/2019 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2019 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Fidelity Southern, Civitas, and MedEquities on Behalf of Stockholders and Encourages Investors to Contact the Firm |
02/04/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
02/04/2019 |
10-Q
| Quarterly Report for the period ended December 31, 2018 |
02/04/2019 |
8-K
| Quarterly results |
01/23/2019 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure |
01/22/2019 |
10-K/A
| Annual Report for the period ended September 30, 2018 [amend] |
01/22/2019 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
01/10/2019 |
SC 13G/A
| FMR LLC reports a 1.2% stake in CIVITAS SOLUTIONS INC |
01/02/2019 |
GN
| Report: Exploring Fundamental Drivers Behind Energy Transfer LP, Cable One, DTE Energy, Civitas Solutions, Owens Realty Mortgage, and Fortress Biotech — New Horizons, Emerging Trends, and Upcoming Developments |
12/28/2018 |
SC 13D
| Centerbridge Capital Partners III, L.P. reports a 54% stake in Civitas Solutions, Inc. |
12/19/2018 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : December 18, 2018 CIVITAS SOLUTIONS, INC. Delaware 001-36623 65-1309110 313 Congress Street, 6th Floor Boston, Massachusetts 02210 790-4800 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 unde...",
"Agreement and Plan of Merger, by and among Civitas Solutions Inc., Celtic Intermediate Corp., and Celtic Tier II Corp",
"Voting Agreement, by and among Celtic Intermediate Corp. and certain stockholders of Civitas Solutions, Inc" |
|
12/19/2018 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
12/19/2018 |
GN
| Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Civitas Solutions, Inc. (CIVI) on Behalf of Stockholders and Encourages CIVI Investors to Contact the Firm |
12/18/2018 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Civitas Solutions, Inc. to Centerbridge Partners, L.P. is Fair to Shareholders |
12/13/2018 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
12/13/2018 |
10-K
| Annual Report for the period ended September 30, 2018 |
12/13/2018 |
8-K
| Quarterly results |
08/31/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : August 28, 2018 CIVITAS SOLUTIONS, INC. Delaware 001-36623 65-1309110 313 Congress Street, 6th Floor Boston, Massachusetts 02210 790-4800 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under...",
"Civitas Solutions, Inc. Announces Appointment of Robert Rosner to its Board of Directors Boston, MA, August 30, 2018 - Civitas Solutions, Inc. today announced that, effective as of August 28, 2018, the Board has approved an increase in its size from eight to nine members and appointed Robert L. Rosner as a Director. Mr. Rosner is an “independent director” as defined by the rules of the New York Stock Exchange. Mr. Rosner will not serve on any committees at this time. Bruce Nardella, Chief Executive Officer and Chair of the Board, stated, “Robert Rosner has been advising and supporting management teams across a wide variety of industries, including healthcare, for more than 30 years, and we are delighted to welcome him to Civitas. We are confident that his impressive breadth of experience a..." |
|
|
|
|